Trade Lonza Group Ltd - LONN
Lonza Group AG (SWX: LONN) is a Swiss contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotech industries. Specializing in biologics, cell and gene therapies, and small molecule APIs, Lonza plays a critical role in scaling complex therapies. With long-term client contracts and global facilities, the company benefits from rising biotech outsourcing and specialty medicine demand. Lonza offers investors a high-quality life sciences supplier with resilient, innovation-led growth.Latest shares articles

Cellnex stock forecast: BlackRock raises stake to 6.398%
Cellnex Telecom is a European telecom-infrastructure company listed in Madrid. In September, BlackRock raised its stake to 6.398% as Cellnex continued its share-buyback programme. Explore third-party CNLX price targets Past performance is not a reliable indicator of future results.
13:15, 28 September 2026

Siemens stock forecast: VinSpeed high-speed rail contract
Siemens is a German industrial group with businesses across automation, infrastructure and mobility. On 22 September 2026, Siemens Mobility signed a high-speed rail contract with VinSpeed. Explore third-party SIE price targets. Past performance is not a reliable indicator of future results.
12:07, 28 September 2026

DeFi Technologies stock forecast: Valour hedge fund launch
DeFi Technologies' subsidiary Valour launched its first hedge fund on 21 September 2026, expanding the business beyond exchange-traded products. Explore third-party DEFT price targets and technical analysis. Past performance is not a reliable indicator of future results.
10:22, 28 September 2026

Buzzi stock forecast: H1 EBITDA and margin pressure
Buzzi is an Italian building-materials group listed in Milan, with recent trading shaped by a September share-price decline and a new investor presentation. Explore third-party BZU price targets and technical analysis. Past performance is not a reliable indicator of future results.
11:07, 25 September 2026
Related News